Infosheet: EMA review of real-world data studies
Submitted by Anonymous (not verified) on 1 August 2024 - 10:10
Infosheet: EMA review of real-world data studies
Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024
Submitted by Anonymous (not verified) on 1 August 2024 - 9:55
Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 10:00 (CET) to 11 December 2024, 12:00 (CET)
Submitted by Anonymous (not verified) on 1 August 2024 - 8:55
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 10:00 (CET) to 11 December 2024, 12:00 (CET)
Antimicrobial Sales and Use (ASU) Platform: Release notes
Submitted by Anonymous (not verified) on 1 August 2024 - 8:54
Antimicrobial Sales and Use (ASU) Platform: Release notes
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2024, 10:00 (CET) to 13 November 2024, 12:00 (CET)
Submitted by Anonymous (not verified) on 1 August 2024 - 8:48
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2024, 10:00 (CET) to 13 November 2024, 12:00 (CET)
Surgiflo haemostatic matrix kit - Ferrosan - Procedural steps and scientific information after initial consultation
Submitted by Anonymous (not verified) on 30 July 2024 - 15:20
Surgiflo haemostatic matrix kit - Ferrosan - Procedural steps and scientific information after initial consultation
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 47, Status: Authorised
Submitted by Anonymous (not verified) on 30 July 2024 - 15:00
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 47, Status: Authorised
Union Product Database: release notes
Submitted by Anonymous (not verified) on 30 July 2024 - 14:55
Union Product Database: release notes
Release notes - production release version 1.7.2427- 30 July 2024 - Veterinary Medical Products Regulation: Union Product Database
Submitted by Anonymous (not verified) on 30 July 2024 - 14:52
Release notes - production release version 1.7.2427- 30 July 2024 - Veterinary Medical Products Regulation: Union Product Database
Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of authorisation: 27/07/2010, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 30 July 2024 - 14:12
Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of authorisation: 27/07/2010, Revision: 21, Status: Authorised